Exelixis, Inc.Exelixis, Inc.Exelixis, Inc.

Exelixis, Inc.

No trades
See on Supercharts
Market capitalization
‪6.82 B‬USD
‪207.77 M‬USD
‪1.83 B‬USD
‪294.81 M‬
Beta (1Y)
0.44

About Exelixis, Inc.

CEO
Michael M. Morrissey
Headquarters
Alameda
Employees (FY)
‪1.31 K‬
Founded
1994
ISIN
US30161Q1040
FIGI
BBG000BQ4WF8
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where EXEL is featured.

Frequently Asked Questions

The current price of EXEL is 22.39 USD — it has decreased by 0.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Exelixis, Inc. stocks are traded under the ticker EXEL.
Exelixis, Inc. is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
EXEL stock is 1.47% volatile and has beta coefficient of 0.44. Check out the list of the most volatile stocks — is Exelixis, Inc. there?
One year price forecast for Exelixis, Inc. has a max estimate of 32.00 USD and a min estimate of 18.00 USD.
Exelixis, Inc. revenue for the last quarter amounts to ‪471.92 M‬ USD despite the estimated figure of ‪473.48 M‬ USD. In the next quarter revenue is expected to reach ‪480.33 M‬ USD.
Yes, you can track Exelixis, Inc. financials in yearly and quarterly reports right on TradingView.
EXEL stock has fallen by 1.37% compared to the previous week, the month change is a 4.36% fall, over the last year Exelixis, Inc. has showed a 17.47% increase.
EXEL net income for the last quarter is ‪85.52 M‬ USD, while the quarter before that showed ‪1.04 M‬ USD of net income which accounts for ‪8.11 K‬% change. Track more Exelixis, Inc. financial stats to get the full picture.
Today Exelixis, Inc. has the market capitalization of ‪6.82 B‬, it has increased by 0.04% over the last week.
No, EXEL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EXEL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Exelixis, Inc. stock right from TradingView charts — choose your broker and connect to your account.
EXEL reached its all-time high on Jul 13, 2000 with the price of 50.50 USD, and its all-time low was 1.26 USD and was reached on Dec 23, 2014.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪1.31 K‬ employees. See our rating of the largest employees — is Exelixis, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Exelixis, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Exelixis, Inc. stock shows the buy signal. See more of Exelixis, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Exelixis, Inc. future price: according to them, EXEL price has a max estimate of 32.00 USD and a min estimate of 18.00 USD. Read a more detailed Exelixis, Inc. forecast: see what analysts think of Exelixis, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Exelixis, Inc. EBITDA is ‪210.58 M‬ USD, and current EBITDA margin is 10.74%. See more stats in Exelixis, Inc. financial statements.